3. Current status of HIV infection in the AIDS Clinical Center (ACC)

Internal Medicine

Volumn 41, Issue 1, 2002, Pages 58-59

  Oka, Shinichi ^a   Yasuoka, Akira ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Desensitization; Drug resistance; Highly active antiretroviral therapy; Morbidity; Mortality; Opportunistic infection

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; COTRIMOXAZOLE; INTERLEUKIN 2; PENTAMIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTEREMIA; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG TOLERABILITY; ENCEPHALITIS; FUNGAL MENINGITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; SIDE EFFECT; TOXOPLASMOSIS;

EID: 0036185403     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.58     Document Type: Conference Paper

References (8)

1. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: A prospective cohort study
2. Accumulation of lopinavir resistance associated mutations over 3 years follow-up of patients on HAART; implication in salvage therapy
3. Anti-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors
4. Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 by using CCR5 expressing HeLa/CD4+ cell clone 1-10 (Magic 5)
5. Clinical benefits of resistance assay for HIV-specific protease inhibitors: When to check and in whom?
6. Complications during clinical courses of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome
7. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S
8. Reduction in IL-2-producing cells but not TH1 to TH2 shift in moderate and advanced stages of disease in human immunodeficiency virus intracellular cytokine concentrations in CD4+CD8- T cells